Soft tissue translocation Flashcards
Alveolar rhabdomyosarcoma
t(2;13)(q35;q14) with PAX3-FOXO1 fusion Most common (60% of cases)
t(1;13)(p36;q14) with PAX7-FOXO1 fusion
Alveolar soft part sarcoma
der(17)t(X;17)(p11;q25) with ASPSCR1-TFE3 fusion
Same gene fusion present in subset of distinctive pediatric renal cell carcinoma
Synovial sarcoma
t(X;18)(p11;q11)
involving SS18 (SYT) gene Fusions and SSX1 (most common), SSX2, or SSX4 (rare) and
Aneurysmal bone cyst of soft tissue
17p13 rearrangements Involves USP6 gene
Nodular fasciitis
t(17;22)(p13;q13) with MYH9-USP6 fusion
Angiofibroma of soft tissue
t(5;8)(p15;q13) with AHRR-NCOA2 fusion
Angiosarcoma
Amplification of 8q24 (MYC)
Characteristic of tumors arising in association with radiation or lymphedema
Lipoblastoma
8q11-13 rearrangements Involves PLAG1
PLAG1 is also seen in PA
Atypical lipomatous tumor
Ring form of chromosome 12;
amplification of MDM2, CDK4, CPM
Same tumor as well-differentiated liposarcoma
Well-differentiated liposarcoma
Ring form of chromosome 12;
amplification of MDM2, CDK4, CPM
Same tumor as atypical lipomatous tumor
Dedifferentiated liposarcoma
Ring form of chromosome 12,
amplification of MDM2, CDK4, CPM by FISH analysis
Also present in atypical lipomatous tumor/well-differentiated liposarcoma
Deep “aggressive” angiomyxoma
Rearrangements of 12q14.3 Involves HMGA2
Also seen in pleomorphic adenomas
Soft tissue chondroma
12q13-15 rearrangements Involves HMGA2
Also seen in PA and deep aggressive angiomyxoma
Dermatofibrosarcoma protuberans
t(17;22)(q21;q13) with COL1A1-PDGFB fusion
Also present in giant cell fibroblastoma
Ring form of chromosomes 17 and 22 Not seen in giant cell fibroblastoma
Giant cell fibroblastoma
t(17;22)(q21;q13) with COL1A1-PDGFB fusion
Also present in dermatofibrosarcoma protuberans
Angiomatoid fibrous histiocytoma
t (2;22)(q33;q12) with EWSR1-CREB1 fusion
Most common (90% of cases); also present in clear cell sarcoma and malignant gastrointestinal neuroectodermal tumor
t(12;22)(q13;q12) with EWSR1-ATF1 fusion
Also present in clear cell sarcoma and malignant gastrointestinal neuroectodermal tumor
t(12;16)(q13;p11) with FUS-ATF1 fusion
Extraskeletal myxoid chondrosarcoma
t(9;22)(q22;q12) with EWSR1-NR4A3 fusion Most common
Clear cell sarcoma
t(12;22)(q13;q12) with EWSR1-ATF1 fusion Most common (90% of cases); also present in angiomatoid fibrous histiocytoma and malignant gastrointestinal neuroectodermal tumor
t(2;22)(q33;q12) with EWSR1-CREB1 fusion Also present in angiomatoid fibrous histiocytoma and malignant gastrointestinal neuroectodermal tumor
Malignant gastrointestinal neuroectodermal tumor
t(2;22)(q33;q12) with EWSR1-CREB1 fusion Also seen in clear cell sarcoma and angiomatoid fibrous histiocytoma
t(12;22)(q13;q12) with EWSR1-ATF1 fusion Also present in clear cell sarcoma and angiomatoid fibrous histiocytoma
Desmoplastic small round cell tumor
t(11;22)(p13;q12) with EWSR1-WT1 fusion
Ewing sarcoma
t(11;22)(q24;q12) with EWSR1-FLI1 fusion Most common (85% of cases)
t(21;22)(q22;q12) with EWSR1-ERG fusion
t(2;22)(q33;q12) with EWSR1-FEV fusion
t(7;22)(p22;q12) with EWSR1-ETV1 fusion
t(17;22)(q21;q12) with EWSR1-ETV4 fusion
Very rare fusions involving FUS
Extrarenal rhabdoid tumor
Deletion of 22q11.2 Inactivation of SMARCB1 (a.k.a. INI1 or SNF5)
Desmoid-type fibromatosis
CTNNB1 (β-catenin gene) mutations in sporadic lesions
APC mutations in tumors arising within setting of Gardner syndrome
Epithelioid hemangioendothelioma
t(1;3)(p36.3;q23-25) with WWTR1-CAMTA1 fusion
Nearly all cases
Infantile fibrosarcoma
t(12;15)(p13;q26) with ETV6-NTRK3 fusion
Identical aberration seen in cellular mesoblastic nephroma of the kidney and MASC
Hemosiderotic fibrolipomatous tumor
t(1;10)(p22;q24) with TGFBR3-MGEA5 fusion
Also present in myxoinflammatory fibroblastic sarcoma
Epithelioid fibrous histiocytoma
2p23 (ALK gene) rearrangements Most cases
Gastrointestinal stromal tumor
KIT, PDGFRA mutations Rare: Mutations in SDH subunit genes (usually SDHB) or NF1
Inflammatory myofibroblastic tumor
2p23 rearrangements Results in ALK gene fusion
Epithelioid sarcoma
22q11-12 abnormalities Inactivation of SMARCB1 (a.k.a. INI1 or SNF5)
Intramuscular myxoma
GNAS gene mutations
Myxoid liposarcoma
t(12;16)(q13;p11) with FUS-DDIT3
PEComa
Deletion of 16p Loss of TSC2
Low-grade fibromyxoid sarcoma
t(7;16)(q33;p11) with FUS-CREB3L2 Most common (65-70% of cases); also present in some cases of sclerosing epithelioid fibrosarcoma
t(11;16)(p11;p11) with FUS-CREB3L1 Rare
Myxoinflammatory fibroblastic sarcoma
t(1;10)(p22;q24) with TGFBR3-MGEA5 fusion
Also present in hemosiderotic fibrolipomatous tumor
Ossifying fibromyxoid tumor
6p21 rearrangements Involves PHF1
Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma
t(7;19)(q22;q13) with SERPINE1-FOSB fusion
Solitary fibrous tumor
12q13 aberrations Intrachromosomal rearrangement results in characteristic NAB2-STAT6 fusion
Mammary-type myofibroblastoma
Loss of 13q14 (RB1)
Same as spindle cell/pleomorphic lipoma and cellular angiofibroma
Spindle cell/pleomorphic lipoma
Loss of 13q14 (RB1)
Also present in mammary-type myofibroblastoma and cellular angiofibroma
Cellular angiofibroma
Loss of 13q14 (RB1)
Same abnormality in mammary-type myofibroblastoma and spindle cell/pleomorphic lipoma
Spindle cell liposarcoma
Loss of 13q14 (RB1)
Chondrosarcoma
IDH1 and IDH2 mutations